Proto-oncogenes encode signaling molecular switches regulating cellular homeostasis in metazoans, and can be converted to oncogenes by gain-of-function mutations. To address the molecular basis for development of the regulatory system of proto-oncogenes during evolution, we screened for ancestral proto-oncogenes from the unicellular choanoflagellate Monosiga ovata by monitoring their transforming activities, and isolated a Pak gene ortholog encoding a serine/threonine kinase as a 'primitive oncogene'. We also cloned Pak orthologs from fungi and the multicellular sponge Ephydatia fluviatilis, and compared their regulatory features with that of M. ovata Pak (MoPak). MoPak is constitutively active and induces cell transformation in mammalian fibroblasts, although the Pak orthologs from multicellular animals are strictly regulated. Analyses of Pak mutants revealed that structural alteration of the auto-inhibitory domain (AID) of MoPak confers higher constitutive kinase activity, as well as greater binding ability to Rho family GTPases than the multicellular Paks, and this structural alteration is responsible for cell transformation and disruption of multicellular tissue organization. These results show that maturation of AID function was required for the development of the strict regulatory system of the Pak proto-oncogene, and suggest a potential link between the establishment of the regulatory system of proto-oncogenes and metazoan evolution.
Introduction
Proto-oncogenes are normal genes that can be converted to oncogenes by gain-of-function mutations (Bishop, 1981; Croce, 2008) . Proto-oncogenes encode various signaling molecules, including tyrosine kinases and serine/threonine kinases, most of which have crucial roles in controlling cell growth and cell-cell communication (Todd and Wong, 1999) . These signaling molecules are characterized by their strict regulatory systems, and mutations in such regulatory systems result in constitutive activation and cause disruption of cell growth control and cell-cell communication, which subsequently leads to cancer progression. However, how and when the proto-oncogenes acquired such a regulatory system during evolution remains to be addressed.
Choanoflagellates are a group of unicellular protists that are regarded as the closest relatives of metazoans (Lang et al., 2002; Philippe et al., 2004) , and are often used as a model for the study of early metazoan evolution (Hibberd, 1975) . Comparative genomic analysis of choanoflagellates and metazoans has shown that choanoflagellates have conserved proteins, such as adhesion molecules, extracellular matrices and various signaling molecules, which are involved in cell-cell communication and multicellularity, many of which were thought to be characteristic of metazoans (King et al., 2003 . This striking finding suggests that the emergence of proto-oncogenes pre-dated the ancestors of metazoans. However, the function of proto-oncogenes in unicellular organisms remains completely unknown.
Previously, we characterized choanoflagellate orthologs of the Src family tyrosine kinase (SFK), a proto-oncogene product involved in cell adhesion, cell migration and cellcell communication (Brown and Cooper, 1996) . In metazoans, the kinase activity of SFK is strictly regulated by the C-terminal Src kinase (Csk) (Nada et al., 1991 (Nada et al., , 1993 Imamoto and Soriano, 1993) . Functional analyses of SFK orthologs from the choanoflagellate Monosiga ovata and from the primitive multicellular animal Ephydatia fluviatilis showed that Src orthologs in M. ovata (MoSrc) are only partially regulated by Csk and have transforming activity, whereas some Src orthologs in E. fluviatilis (EfSrc) are strictly regulated in a manner similar to mammalian SFKs (Segawa et al., 2006) . Similar results were also reported for SFK orthologs in another choanoflagellate, M. brevicollis (Li et al., 2008) . These observations suggest that there might be a critical transition in the regulatory system of proto-oncogenes during the early evolution of metazoans. However, whether this would also be the case for other protooncogenes needs to be addressed.
In this study, we comprehensively screened proto-oncogenes in M. ovata, by monitoring their transforming activities in mammalian cells, and isolated a Pak gene ortholog as a transient state proto-oncogene. Pak kinase (p21-activated kinase) is an effector of the small GTPase Rac and Cdc42 (Manser et al., 1994) , and has a pivotal role in diverse cellular processes, including cytoskeletal remodeling, motility, proliferation and transformation (Bokoch, 2003) . The Pak gene is highly conserved during the evolution of fungi and animals (Hofmann et al., 2004) , and the kinase activity of mammalian Pak is strictly regulated by the N-terminal auto-inhibitory domain (AID) Lei et al., 2000) . In mammals, the Pak family members are classified into group I (Pak1-3) and group II (Pak4-6). Group I Paks are strongly activated by binding to Rac or Cdc42, whereas group II Paks are not appreciably activated by GTPases. As aberrant Pak kinase activity was implicated in a variety of human cancers (Kumar et al., 2006) , the Pak gene is regarded as a protooncogene.
To address the molecular basis of the functional alteration in Pak orthologs during early metazoan evolution, we carried out a comparative analysis of Pak orthologs from fungi, M. ovata, E. fluviatilis and human. We found that fungal Pak and M. ovata Pak (MoPak) have an immature regulatory system, and can serve as an oncogene in mammalian cells, whereas E. fluviatilis Pak (EfPak) and human Pak (hPak1) are strictly regulated. This result suggests that there may be a critical transition in the Pak regulatory system during early evolution of metazoans. The study of MoPak also contributes to the unraveling of a mechanism for cell transformation induced by oncogenic Pak.
Results
Isolation of a Pak gene ortholog as an oncogene from M. ovata To identify proto-oncogenes whose functions were altered during the early evolution of metazoans, we carried out a comprehensive screening of 'oncogenic' proto-oncogenes from M. ovata. We transfected the retroviral M. ovata cDNA library into rat 3Y-1 cells, and screened genes by monitoring the acquisition of anchorage-independent growth on soft agar. Although MoSrc was isolated as a major oncogene, a potential Pak gene ortholog, termed MoPak, was identified as an oncogenic proto-oncogene in M. ovata (Supplementary  Table I ). To analyze the functional transition of MoPak during metazoan evolution, we also cloned a potential Pak gene ortholog from the primitive metazoan E. fluviatilis (EfPak) for comparison.
MoPak and EfPak contain conserved domains characteristic of the Pak family, such as the p21-binding domain consisting of the Cdc42/Rac interactive binding (CRIB) motif and the AID, and the serine/threonine kinase domain (Figure 1a ; Supplementary Figure S1a ). Phylogenetic analysis placed these Pak orthologs in the Pak subgroup of serine/threonine kinases (Supplementary Figure S2 ), and showed that they have higher similarity to the group I Pak family (Pak1-3) than qgroup II (Pak4-6) ( Figure 1a ; data not shown). As no apparent paralog of Pak was identified in M. ovata genomic sequences (unpublished observation), MoPak may be an original isoform of the multiple Paks in metazoans. Domain alignment of these Pak orthologs revealed that the kinase domains of both MoPak and EfPak are most similar to that of hPak1 with 79 and 86% amino-acid identity, respectively. Accordingly, we concluded that MoPak and EfPak are orthologs of hPak1. In contrast, the N-terminal CRIB-AID domain significantly differs between MoPak and EfPak, with the identities to that of hPak1 being 51 and 72%, respectively. In addition, EfPak and hPak1 have a Pakinteractive exchange factor (PIX)-binding domain, whereas MoPak does not (Figure 1a ). These findings suggest that the N-terminal regulatory domain was significantly altered during evolution from a unicellular ancestor to metazoans, whereas the C-terminal kinase domain of Pak was highly conserved during this evolutional transition.
MoPak has transforming activity, but EfPak does not
We compared the functions of MoPak and EfPak in 3Y-1 cells (Figure 1b) . MoPak induced colony formation in soft agar, whereas EfPak did not (Figure 1c ; Supplementary Figure S3a) . MoPak also induced a spindle-like cellular morphology and a dramatic reduction in actin stress fibers, whereas EfPak did not significantly affect cell morphology and actin organization ( Figure 1d ). Furthermore, a tumorigenesis assay in nude mice showed that MoPak, but not EfPak, had the ability to grow tumors in vivo (Figure 1e ; Supplementary Figure S3b ). These results indicate that MoPak has transforming activity, but EfPak does not.
The function of MoPak and EfPak was further verified using MCF-10A cells, a mammary glandderived epithelial cell line that develops an acinous structure in three-dimensional culture (Debnath et al., 2003) . EfPak had no effect on acinar growth or morphogenesis, whereas MoPak induced hyperproliferation accompanied by disorganized tissue structures (Supplementary Figures S4a and b) . In addition, MoPak-expressing cells grew within the spherical structures ( Supplementary Figures S4c and d) and occupied the luminal spaces (Supplementary Figures  S4e and f) , indicating that MoPak impedes contact inhibition of cell growth and luminal apoptosis. The suppressive effect of MoPak on contact inhibition was also observed in human epithelial HaCat cells (Supplementary Figure S5 ). These findings show that MoPak cannot support multicellular tissue organization because of its transforming activity.
We further examined the transforming activity of fungal Pak orthologs (Hofmann et al., 2004) . Pak orthologs were cloned from the unicellular fungi, Schizosaccharomyces pombe (pPak: orb2) and Saccharomyces cerevisiae (cPak: STE20), and from the multicellular fungus Neurospora crassa (nPak: NCU00406.1). Interestingly, we found that all these fungal Paks, pPak, cPak and nPak have transforming activity in 3Y-1 cells regardless of whether they were of unicellular or multicellular origin (Figure 1f ). These findings suggest that the function and/or regulatory activity of Pak may have been specifically altered during the evolution of metazoans.
MoPak is constitutively active
To address the molecular basis of the unique feature of MoPak, we first compared its kinase activity with those of multicellular Paks. The kinase activity of immunopurified Pak was determined by an in vitro kinase assay using myelin basic protein (MBP) as a substrate. 
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As shown in Figure 2a , MoPak significantly phosphorylated MBP, whereas EfPak showed no detectable kinase activity. The kinase activity of mammalian Pak is inhibited by the N-terminal AID Lei et al., 2000) . Indeed, hPak1 showed no apparent activity, but its AID mutant hPak1L107F, which has a Leu to Phe substitution at the critical site in the AID, showed increased activity ( Figure 2a , right panels). Consistently, EfPakL95F showed strong kinase activity ( Figure 2a , left panels) and gained transforming activity (Figure 2d ), indicating that EfPak has a negative regulatory system through the AID in a manner similar to mammalian orthologs. The AID mutant of MoPak (MoPakL59F) also had higher activity than wild-type MoPak (Figure 2b ), reaching levels of activity comparable to that of EfPakL95F. Morphological studies ( Figure 2c ) and colony formation assays (Figures 2d and e) showed that the loss of AID function in MoPak could enhance its transforming ability. However, the extent of activation of MoPak by the AID mutation was more moderate than that of the multicellular Paks. These results suggest that the AID of MoPak is functional, but is not sufficiently developed for achieving full inactivation.
The CRIB-AID domain is important for the transforming activity of MoPak To locate the domain responsible for the constitutive activity of MoPak, we constructed chimeric Paks consisting of the functional domains of MoPak and EfPak, and analyzed their functions in 3Y-1 cells Figure S6 ). The MoPak chimera in which the N-terminal regulatory half was replaced with that of EfPak (Figure 3c ; EMPak) did not induce cell transformation, whereas the EfPak chimera containing the N-terminal half of MoPak (MEPak) induced transformation, indicating that the N-terminal regulatory region of MoPak is critical for its transforming activity. When the N-terminal region of the MEPak chimera was replaced with the region up to the AID (3MEPak and 4MEPak) of EfPak or the region containing the PIX-binding domain (2MEPak), the MEPak chimeras still retained transforming activity (Figure 3c ). In contrast, the replacement of the N-terminal region up to the CRIB motif with that of EfPak largely reduced transforming, as well as kinase activity (5MEPak) (Figures 3c and d) . Conversely, the replacement of the N-terminal region containing both the CRIB motif and the AID domain of EfPak with that of MoPak completely suppressed the transforming activity of MoPak (2EMPak), whereas replacement of the region containing only the CRIB motif restored significant transforming and kinase activity (3EMPak) (Figures 3c  and d) . These results suggest that the combination of the AID domain and the CRIB motif is critical for regulating both MoPak and EfPak. EfPak has a longer N-terminal region upstream of the CRIB motif than MoPak. However, SEfPak, which has a short truncation of the N-terminus of EfPak, was not transforming (Figure 3c) , and the N-terminus upstream of the CRIB motif of EfPak did not suppress transformation (4EMPak). These data indicate that there is no significant contribution of the N-terminus to the regulation of Pak function. Furthermore, the kinase activity of these chimeras was well correlated with their transforming activity, supporting the observation that transforming activity of Pak is dependent on its kinase activity (Figure 3d ).
MoPak has greater binding ability to Rac1 or Cdc42 than EfPak
The CRIB motif is a minimal binding sequence for the activated Rac or Cdc42, and Rac/Cdc42-CRIB binding induces a dramatic activation of Pak activity (Lei et al., 2000) . To examine whether the CRIB motif is involved in the transforming activity of MoPak, we investigated the interaction of Pak orthologs with Rac1 or Cdc42 using an immunoprecipitation assay. As shown in Figure 4a , MoPak bound to Rac1 or Cdc42 more strongly than EfPak. A control mutant, MoPakH35,38L, which lacks the CRIB function, exhibited only background binding, thus confirming the specific binding through the CRIB motif (Figure 4a ). The interaction of MoPak with hRac1 was confirmed by an in vitro pull-down assay using a recombinant hRac1 activated by nonhydrolyzable GTPgS (Figure 4b) . Furthermore, the effects of binding to Rac1 or Cdc42 on the kinase activity of MoPak or EfPak were examined using constitutively active Rac1V12 or Cdc42V12. MoPak was activated by both Rac1V12 Evolution of Pak proto-oncogene A Watari et al and Cdc42V12 to a level significantly greater than that of EfPak activation (Figure 4c) . However, the fold activation of MoPak by Rac1V12 or Cdc42V12 appeared to be lower than that of EfPak. This is because MoPak has a substantial level of constitutive activity, whereas EfPak is almost fully inactive in the absence of Rac1V12 or Cdc42V12. These results indicate that, compared with EfPak, MoPak binds Rac1 or Cdc42 more efficiently, thereby further increasing its activity. In contrast, the activity of EfPak is strictly dependent on its binding to Rac1 or Cdc42.
To examine the possibility that the function of Rac or Cdc42 would also be altered during the evolutional transition, we focused on Rac and cloned Rac1 orthologs from M. ovata (MoRac43 and MoRac91) and from E. fluviatilis (EfRac1), and compared their functions. Phylogenetic analysis indicated that MoRac43, 91 and EfRac1 are Rac orthologs in M. ovata and E. fluviatilis (data not shown). Alignment of the aminoacid sequences of these Rac orthologs showed that these Rac orthologs are strikingly similar to each other, with the amino-acid identity being over 90% (Supplementary Figure S1b ). The interaction between Rac and Pak orthologs was confirmed using an in vitro pull-down assay. MoRac43 and MoRac91 activated by GTP were capable of binding to MoPak (Figure 5a ), as well as EfPak (Figure 5b) . Similarly, the activated EfRac1 could bind to EfPak (Figure 5b ) and MoPak (Figure 5a ). However, the binding ability of MoPak to Rac orthologs was substantially higher than that of EfPak, as indicated by the increased amount of bound Rac (Figures 5a and b) . These findings show that Rac orthologs are highly conserved and interchangeable in their ability to bind to Pak orthologs, and that MoPak has the greatest binding ability to either Rac ortholog.
We next examined the effects of Rac binding on the in vitro kinase activity of Pak orthologs. These assays revealed that MoPak had significant kinase activity even in the absence of activated MoRac, and that the addition of the activated MoRacs further enhanced its activity (Figure 5c ). In contrast, EfPak had only low activity, and its Rac-dependent activity was also substantially lower than that of MoPak (Figure 5d ). Similar results were obtained when hRac1 was used (Figure 5e ). These results confirm that MoPak has greater binding ability to Rac, and is efficiently activated by Rac binding.
The overall structure of the CRIB-AID domain of MoPak is responsible for its increased binding ability to Rac
We addressed the molecular basis for the increase binding ability of MoPak to Rac. An alignment of the The interaction of MoPak and EfPak with human Rac1 was analyzed by pull-down assay. The GST-hRac1 proteins loaded with GTPgS or GDP were incubated with the purified FLAG-tagged Pak proteins, and the proteins bound to GST-hRac1 were detected by western blotting with anti-FLAG antibody. Loaded Pak proteins and GST-hRac1 proteins were detected by western blotting and Coomassie Brilliant Blue staining, respectively. (c) 3Y-1 cells expressing indicated Pak proteins were transfected by a constitutively active Rac1 or Rac1V12 (left), and Cdc42 or Cdc42V12 (right). Pak kinases were then immunoprecipitated and subjected to an in vitro kinase assay. Phosphorylation of MBP was quantified using the image J program (National Institutes of Health), and the relative kinase activity is shown (t-test: *Po0.05, **Po0.01).
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A Watari et al primary sequences of CRIB motifs from various Pak orthologs showed that nontransforming Pak orthologs in metazoans have conserved Glu and Thr residues at the sites corresponding to MoPak ILe34 and Glu36, respectively (Figure 6a ). Thus, we generated a MoPak mutant with Ile34 to Glu and Glu36 to Thr substitutions (MoPakI34E, E36T), and an EfPak mutant with Glu70 to Ile and Thr72 to Glu substitutions (EfPakE70I, T72E), and examined their transforming activity. These substituted mutants did not affect the transforming activity of either Pak ortholog (Figure 6b ). We also interchanged the CRIB motif between MoPak and EfPak, but this did not affect their transforming activities (Figure 6c ). These results show that there is no significant difference in the function of the CRIB motif itself. However, it has been reported that sequences in the AID contribute to the overall binding affinity for GTPases (Sells et al., 1997; Knaus et al., 1998; Lei et al., 2000) , indicating that the combination of the CRIB motif and the AID defines the affinity for GTPases. Thus, we compared the binding ability to Rac1 among the transforming MoPak, MoPakL59F and EfPakL95F (Figure 6d ). An immunoprecipitation assay revealed that MoPak and the AID mutants efficiently bound to Rac1, whereas nontransforming Paks showed much lower binding ability to Rac1. It has been shown that the AID mutant hPakL107F has an Figure 5 The Pak-Rac interaction was highly conserved during evolution, but MoPak has greater binding ability to Rac than EfPak. (a, b) The interaction of MoPak (a) and EfPak (b) with Rac orthologs in M. ovata (MoRac43 and MoRac91) and E. fluviatilis (EfRac1) was analyzed by pull-down assay. The indicated GST-Rac proteins loaded with GTPgS or GDP were incubated with the purified FLAG-tagged Pak proteins, and the proteins bound to GST-Rac were detected by western blotting with anti-FLAG. Loaded Pak proteins and GST-Rac proteins were detected by western blotting and Coomassie Brilliant Blue staining, respectively. (c) The purified MoPak was incubated with the indicated MoRac proteins and subjected to an in vitro kinase assay. (d) The purified MoPak or EfPak was incubated with the indicated EfRac1 proteins, and subjected to an in vitro kinase assay. (e) MoPak or EfPak was incubated with the indicated form of GST-hRac1 and subjected to an in vitro kinase assay.
Evolution of Pak proto-oncogene A Watari et al unfolded AID, because Leu107 is essential for stabilizing the hydrophobic core of this domain (Lei et al., 2000) . The orthologous mutants, MoPakL59F and EfPakL95F, are also expected to have an unfolded AID. Therefore, these results show that the AID of wild-type MoPak adopts a unique conformation that allows it to access Rac1 as efficiently as the AID mutants. These results suggest that conformational features of the AID underlie the enhanced CRIB-Rac1 interaction that is crucial for the transforming activity of MoPak.
The hPak1 kinase is auto-inhibited in trans by the interaction between the AID and the catalytic site in a homodimer (Lei et al., 2000; Parrini et al., 2002) .
As MoPak has the critical residues for homodimer formation in the AID and the catalytic site, we examined whether MoPak could form homodimer. A co-immunoprecipitation assay of Myc-and FLAGtagged Paks revealed that MoPak, as well as EfPak, is capable of forming homodimers ( Figure 6e) ; this indicates that homodimer formation of Pak molecules is conserved even in unicellular organisms. However, the auto-inhibition of MoPak activity is incomplete (Figure 2b) , and MoPak can efficiently bind to Rac1 (Figure 6d ). These results suggest that the homodimer of MoPak may not be stable enough to fully inhibit the kinase activity or the binding to Rac1, or there may be a dynamic equilibrium between homodimer and monomer. Thus, it is likely that the CRIB-AID domain of MoPak cannot adopt a stable structure that is sufficient to strictly regulate MoPak function (Figure 7d ).
MoPak-induced cell transformation requires the association with Rac/Cdc42
In this study, we found that the CRIB mutant MoPakH35,38L did not induce cell transformation, even though it had kinase activity almost comparable to that of wild-type MoPak (Figure 7a) . A similar loss of transforming activity was observed for the CRIB mutants of the active form of multicellular Pak orthologs (EfPakL95F, H71,74L and hPAk1L107F, H83,86L; Figures 7b and c) . The transforming activity of fungal Pak was also abolished by the mutation in the CRIB motif (Supplementary Figure S7) . These observations suggest that the CRIB-Rac/Cdc42 interaction has a critical role in Pak-induced cell transformation. A kinase-active hPak1 mutant, hPak1T423E, which contains a Thr to Glu substitution in the activation loop to mimic autophosphorylation, is defective for cell transformation (Tang et al., 1997; Vadlamudi et al. , Figure 6 The overall structure of the CRIB-AID domain of MoPak is responsible for its increased binding ability to Rac1/Cdc42. (a) Amino-acid alignment of the CRIB motif of various species. Nonconserved amino acids in the oncogenic Pak are shown in gray. Asterisks (*) indicate positions which have a single, fully conserved residue. Colons (:) indicate that one of the strong groups having a similarity score greater than 0.5 in the Gonnet Pam250 matrix is fully conserved. (b) Colony formation assay using 3Y-1 cells expressing MoPak or EfPak mutants in which nonconserved amino acids were replaced with conserved ones. Representative plates from three independent experiments are shown. (c) Colony formation assay using 3Y-1 cells expressing MoPak or EfPak mutant in which the CRIB motif was interchanged. MoPak-CE has the EfPak CRIB, and EfPak-CM has the MoPak CRIB. Representative plates from three independent experiments are shown. (d) Interaction of the active form of MoPak or EfPak with Rac1 was analyzed by immunoprecipitation from 3Y-1 cells expressing the indicated Pak mutants as described in the legend to Figure 4a . (e) The homodimer formation of MoPak and EfPak was analyzed by co-immunoprecipitation from 3Y-1 cells expressing Myc-and FLAG-tagged MoPak and EfPak. The indicated Pak was immunoprecipitated with anti-Myc (left) and anti-FLAG (right) antibody, followed by western blotting with antiMyc and anti-FLAG antibodies. Total MoPak and EfPak proteins were also detected by western blotting. The specificity of this immunoprecipitation assay was confirmed by the observation that western blotting with anti-FLAG antibody for the immunoprecipitates with anti-Myc antibody from cells expressing only MoPak-FLAG or EfPak-FLAG gave no detectable signals (data not shown).
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. However, we found that a kinase-active MoPak mutant, MoPakT351E, could induce cell transformation (Figure 7a ), whereas the corresponding EfPak mutant, EfPakT415E, did not (Figure 7b ). These results suggest that full activation and efficient interaction with Rac1/Cdc42 are required for inducing cell transformation (Figure 7d ).
Discussion
To address the question of when and how the protooncogenes acquired a strict regulatory system during evolution, we screened ancestral proto-oncogenes from M. ovata, a potential unicellular ancestor of metazoans, and identified a Pak ortholog as a novel transient state The kinase activity and transforming activity of the indicated EfPak mutants were examined as described in (a). (c) The kinase activity and transforming activity of the indicated hPak1 mutants were examined as described in (a).
(d) A schematic model of the functional difference between MoPak and EfPak. In EfPak, the kinase domain and the binding surface to Rac1/Cdc42 can interact tightly in by a homodimer, thereby showing no significant kinase activity and only a low binding ability to Rac1/Cdc42 in a quiescent state. In contrast, the CRIB-AID domain of MoPak may be loosely packed or unstable, which allows efficient access to activated Rac1/Cdc42 leading to cell transformation.
Evolution of Pak proto-oncogene A Watari et al proto-oncogene. Comparative analyses of the regulatory features of Pak orthologs from fungi, M. ovata, E. fluviatilis and human suggested that the strict regulatory system of Pak was developed during evolution from unicellular ancestor to metazoans. Previously, we showed that the strict regulation of the Src protooncogene has emerged from the multicellular E. fluviatilis (Segawa et al., 2006) . These observations support the assumption that there was a functional transition in the proto-oncogene during the early evolution of metazoans, which might be advantageous for adapting and maintaining multicellular life. We found that MoPak is constitutively active, whereas multicellular Pak is usually present as an inactive form. Analyses of Pak chimeras and point mutants showed that the N-terminal regulatory domain of MoPak, consisting of the CRIB motif and the AID, is responsible for its constitutive activity, as well as transforming activity. In particular, the alteration in the AID seemed to be critical, because the mutation in the AID of MoPak induced only moderate activation, whereas those of multicellular Paks conferred greater activity, sufficient for inducing cell transformation. The AID in hPak1 is involved in homodimer formation by interacting with the catalytic site of another molecule; homodimer formation is critical for auto-inhibition in trans (Lei et al., 2000; Parrini et al., 2002) . We found that MoPak is also able to form homodimer, although it cannot be fully auto-inhibited. This result suggests that the MoPak homodimer is structurally unstable, or that there may be a dynamic equilibrium between an inactive homodimer and an active monomer, probably because of the unique feature of the AID structure. Although it is possible that the higher-order structure or the flexibility of the AID may contribute to these unique features of MoPak, more extensive structural analysis of MoPak will be necessary to verify this possibility.
In this study, we also showed that the increased binding ability to activated Rac1/Cdc42 through the CRIB motif is critical for the transforming activity of MoPak. The mutations in the CRIB motif of MoPak completely abrogated its transforming activity. Likewise, the CRIB mutants of the transforming multicellular Pak mutants lost their transforming activities. These findings suggest that the CRIB-mediated interaction with activated Rac1/Cdc42 is generally required for Pak-mediated cell transformation. The AID is involved not only in the inhibition of the kinase domain, but also in the specific recognition of GTPase (Lei et al., 2000; Reeder et al., 2001) . Thus, it is likely that the CRIB motif and the AID of MoPak are unmasked because of the unique conformational features of the AID, thereby allowing efficient access to activated Rac1/Cdc42 (Figure 7d ). However, an hPak1 mutant that lacks a binding site for Rac was shown to promote the transforming activity of some cancer cells, suggesting that the CRIB motif has a suppressive role in cancer progression (Vadlamudi et al., 2000; O'Sullivan et al., 2007) . Although the reason for this discrepancy is currently unclear, hPak1 may have additional functions, such as enhanced autophosphorylation and scaffolding , independent of kinase activity (Frost et al., 1998; Higuchi et al., 2008) . These functions may affect other pathways linked to cancer progression.
Pak regulates cell-cell interactions by modulating E-cadherin-mediated adhesion (Lozano et al., 2008) . A study in Dictyostelium discoideum showed that the expression of a constitutively active mutant of PakA induces defects in cell aggregation and inhibits formation of mounds (Chung and Firtel, 1999) . We also showed that the expression of MoPak in MCF-10A cells greatly impaired contact inhibition of cell growth and maintenance of cell polarity, thereby abrogating acinar formation in three-dimensional culture. These results suggest that the strict regulatory system of Pak is required for development and maintenance of multicellular society. However, there are many protooncogenes in metazoans whose dysregulation leads to destruction of multicellular society, and some of them have orthologs in choanoflagellates, such as Abl and Tec Manning et al., 2008; Suga et al., 2008) . As dysregulation of only a single proto-oncogene, such as Pak or Src, is sufficient for disrupting multicellularity, accumulated alteration of proto-oncogenes is required to establish the multicellular society in metazoans. It should also be noted that unicellular organisms may have proactively adopted 'oncogenic' proto-oncogenes for their single life. Cancer is associated with the disruption of a multicellular society by the accumulation of mutations in proto-oncogene or tumor-suppressor genes. In contrast, the unicellular protists have premature proto-oncogenes such as MoPak and MoSrc, which we have designated 'primitive oncogenes', and survive without direct cell-cell communication (Supplementary Figure S8) . On the basis of this interesting analogy, our study supports the previous notion that cancer cells may represent a reversion to an ancestral unicellular creature (Johnston et al., 1992) . Further analysis of primitive oncogenes will offer new clues for understanding the mechanisms underlying the destruction of a multicellular society in cancer.
Materials and methods

cDNA cloning
Total RNA of M. ovata and E. fluviatilis were obtained using the Isogene reagent (Wako, Osaka, Japan) as previously described (Suga et al., 2001) , and poly(A) þ RNAs were selected using oligo(dT)-cellulose. The poly(A) þ mRNAs were reverse transcribed to cDNAs using oligo(dT) primer with reverse transcriptase (Superscript II, Invitrogen, San Diego, CA, USA). For cloning EfPak and EfRac1, E. fluviatilis cDNAs were subjected to high-fidelity PCR with degenerate primers. The sense (S) and antisense (AS) degenerate primers were designed from the converse stretches of amino acids as follows (in IUB code).
EfPak ( The PCR-amplified fragments were purified and then sequenced using a BigDye sequencing kit (ABI, Foster City, CA, USA). 5 0 and 3 0 sequences of MoPak, MoRac43, MoRac91, EfPak and EfRac1 were obtained by 3 0 and 5 0 RACE. The PCR-amplified fragments were purified and cloned into the pCX4bleo (MoPak and EfPak) vector for expression in mammalian cells. Rac1 and Cdc42 (gifts from M Matsuda) were subcloned into the pCX4puro vector. The hPak1, pPak (orb2), cPak (STE20) and nPak (NCU00406.1) cDNAs obtained by high-fidelity PCR were cloned into the pCX4bleo vector. The accession numbers (DDBJ) of MoPak, EfPak, MoRac43, MoRac91 and EfRac1 are AB510951, AB510952, AB510953, AB510954 and AB510955, respectively.
Construction of retrovirus vector and virus production
A pCX4 series (Moloney murine leukemia virus-based retrovirus vectors containing resistance genes, such as bleomycin or puromycin, as selectable markers) was constructed by Akagi et al. (2000) . Various Pak ortholog mutants were generated using a PCR-based procedure. Plat-E cells (Morita et al., 2000) were transfected with various constructs using FuGene 6 (Roche, Basel, Switzerland) according to the manufacturer's instructions. At 2 days after transfection, the culture supernatants were collected and stored at À80 1C until use.
In vitro kinase assays The immunoprecipitated Myc-tagged Pak, or the purified FLAG-tagged Pak, was mixed with glutathione S-transferaseRac loaded with GTPgS or GDP and incubated with 0.5 mg of MBP and g-32 P ATP in a kinase buffer (20 mM Tris-HCl, pH 7.5, 5 mM MgCl 2 , 0.1 mM ATP). After incubation for 20 min at 32 1C, the reactions were terminated by adding SDS sample buffer, boiled for 5 min and separated by SDS polyacrylamide gel electrophoresis. MBP phosphorylation was detected by autoradiography. The signal intensities for Pak and phosphorylated MBP were quantified by using the Image J program (National Institutes of Health), and the relative activities were plotted.
